Intuitive Surgical Inc. (ISRG) maintains a dominant monopolistic position in the robotic-assisted surgery market, underpinned by a massive installed base of over 11,300 systems and a "razor-and-blade" revenue model where 86% of sales are recurring. Financial analysis reveals a robust compound annual growth rate and a fortress balance sheet with over $9 billion in liquidity and negligible debt, though gross margins have faced structural compression due to new product rollouts and protectionist trade policies. Despite macroeconomic headwinds such as tariffs and international pricing pressures in China, ISRG's future outlook remains positive, driven by the accelerating adoption of the fifth-generation da Vinci 5 platform and a growing data moat from 20 million historical procedures that positions the company to lead in AI-enabled clinical decision s ...